retatrutide nonalcoholic fatty liver disease nash trial steatohepatitis Retatrutide: A Promising Breakthrough for Nonalcoholic Fatty Liver Disease in retatrutide nonalcoholic steatohepatitis nash trial

Important Note: The telehealth weight loss industry, particularly platforms offering compounded GLP-1 medications, has been under increased regulatory scrutiny in recent years

Retatrutide data drawn from preclinical and phase 2 investigational publications

Beyond stimulating insulin, GLP-1 improves the function and viability of the pancreatic beta cells, which are the cells responsible for making and releasing insulin

For example, if a 10mg vial is diluted with 2mL of bacteriostatic water, the concentration is 5,000mcg/mL

GLP-1 medications can influence thyroid hormone levels which directly disrupts your hair growth cycle

Smaller meals mean less volume for your slowed stomach to process at once, less fermentation, less gas, and a more gradual delivery of nutrients to the intestines